Adrenal, Pituitary and Neuroendocrine Strategies for Endocrinologists
CME Credits:
4.25
MOC Credits:
4.25

Online

Adrenal, Pituitary and Neuroendocrine Strategies for Endocrinologists

Strengthen your patient care skills and discover the top clinical research in AACE’s Adrenal, Pituitary and Neuroendocrine Strategies for Endocrinologists course. Leading faculty discuss cases and treatment on key topics including pheochromocytoma and paraganglioma, imaging features of an adrenal adenoma, treatment of functional neuroendocrine tumors, and more

Take your adrenal, pituitary, and neuroendocrine knowledge to the next level! This collection of lectures features the most recent and relevant topics in the field of Endocrinology. This online course contains video lectures, assessment questions, and the opportunity for CME and MOC!

4.25
CME/MOC Credits
3
Faculty
4
Lectures

Starts 7/21/2022 | Expires 7/21/2023

Lectures Included

  • Disease State Network Year-in-Review: PGAN
  • The New Biology of Pheochromocytomas
  • Adrenal Imaging Strategies: Which and When
  • Neuroendocrine Tumors: Current Therapeutic Strategies and Views for Neuroendocrine Tumors

Learning Objectives

Upon completion of the activity, participants should be able to:

  • Evaluate the latest clinically-relevant articles on adrenal, pituitary and gonad disorders
  • Outline the newest discoveries regarding functional imaging of pheochromocytoma and paraganglioma, including newest imaging guidelines and treatment options related to metastatic tumors focusing on personalized medicine
  • Recognize the imaging features of an adrenal adenoma from a non-adenoma, pheochromocytomas and adrenal cortical carcinomas
  • Recognize the clinical features and current safety and efficacy of medical management of functional neuroendocrine tumors
Faculty

Faculty

Aliya A. Khan, MD, FRCPC, FACP, FACE, FASBMR

Bart L. Clarke, MD

Robert A. Wermers, MD, FACE

Accreditation

Target Audience

This educational initiative is intended for Endocrinologists.

Accreditation Statement

The American College of Endocrinology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The American College of Endocrinology designates this enduring activity for a maximum of 4.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.25 MOC Medical Knowledge point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Disclosures/Conflicts of Interest

Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, The American Association of Clinical Endocrinology (AACE) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. AACE resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AACE seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AACE is committed to providing learners with high-quality CME.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, and other members at the American Association of Clinical Endocrinology who control content have no relevant financial relationships to disclose.

Faculty Disclosures

FirstMILastCredentialsPositionInstitutionRoleDisclosure(s)
AliyaA.KhanMD, FRCPC, FACP, FACE, FASBMRProfessor of Clinical MedicineMcMaster UniversitySpeakerAlexion (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing); Amgen (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing); Amolyt (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing); Ascendis (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing); Chugai (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing); Radius (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing); Takeda (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing); Ultragenyx (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing)
BartL.ClarkeMDProfessor of MedicineMayo Clinic College of Medicine; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo ClinicSpeakerAscendis, Inc. (Self) : Research Grant (Status: Ongoing); Bristol Myers Squibb (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Data Monitoring Committee (Status: Ongoing); Chugai Pharmaceuticals (Self) : Research Grant (Status: Terminated --- 7/1/2021); Takeda (Self) : Research Grant (Status: Ongoing)
RobertA.WermersMD, FACEProfessor of Medicine Mayo Clinic College of Medicine and Consultant and Chair Division of Endocrinology, Diabetes, Metabolism and Nutrition Mayo Clinic RochesterMayo Clinic College of Medicine; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo ClinicSpeakerNothing to disclose

 

Disclosure of Unlabeled Use

AACE requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. AACE does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Disclaimer

The American Association of Clinical presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The American Association of Clinical Endocrinology assumes no liability for the information herein.